Allotment of scrip shares

RNS Number : 8074T

The MedicX Fund Limited

04 October 2010

 



For immediate release                                                                                                    4 October 2010

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Allotment of scrip shares to Chairman and Investment Adviser

David Staples (the Company's Chairman) and MedicX Adviser Ltd (the Company's Investment Adviser) elected to participate in the Company's scrip dividend scheme in respect of the September 2010 interim dividend for the quarter ended 30 June 2010, and accordingly were allotted 575 and 11,511 new ordinary shares of no par value in the Company (the "Shares") respectively.  The Shares were admitted to the Official List of the FSA and to trading on the Main Market of the London Stock Exchange on 30 September 2010 and rank pari passu with the Company's existing ordinary shares.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.hemscott.com/nsm.do).

End

For further information please contact:

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Managing Director

Mark Osmond, Chief Financial Officer

Collins Stewart Europe Limited                                        [phone]

Andrew Zychowski/Lucy Lewis

Buchanan Communications                                              [phone]

Charles Ryland/George Prassas

MedicX Fund Limited                                                       [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 57 properties.

 The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 35 people operating across the UK.  

 The Company's website address is www.medicxfund.com.

 

END

 

 

RDSLLFSLIALSIII